<?xml version='1.0' encoding='utf-8'?>
<document id="17261397"><sentence text="Effect of atorvastatin and pravastatin on platelet inhibition by aspirin and clopidogrel treatment in patients with coronary stent thrombosis."><entity charOffset="10-22" id="DDI-PubMed.17261397.s1.e0" text="atorvastatin" /><entity charOffset="27-38" id="DDI-PubMed.17261397.s1.e1" text="pravastatin" /><entity charOffset="65-72" id="DDI-PubMed.17261397.s1.e2" text="aspirin" /><entity charOffset="77-88" id="DDI-PubMed.17261397.s1.e3" text="clopidogrel" /><pair ddi="false" e1="DDI-PubMed.17261397.s1.e0" e2="DDI-PubMed.17261397.s1.e0" /><pair ddi="false" e1="DDI-PubMed.17261397.s1.e0" e2="DDI-PubMed.17261397.s1.e1" /><pair ddi="false" e1="DDI-PubMed.17261397.s1.e0" e2="DDI-PubMed.17261397.s1.e2" /><pair ddi="false" e1="DDI-PubMed.17261397.s1.e0" e2="DDI-PubMed.17261397.s1.e3" /><pair ddi="false" e1="DDI-PubMed.17261397.s1.e1" e2="DDI-PubMed.17261397.s1.e1" /><pair ddi="false" e1="DDI-PubMed.17261397.s1.e1" e2="DDI-PubMed.17261397.s1.e2" /><pair ddi="false" e1="DDI-PubMed.17261397.s1.e1" e2="DDI-PubMed.17261397.s1.e3" /><pair ddi="false" e1="DDI-PubMed.17261397.s1.e2" e2="DDI-PubMed.17261397.s1.e2" /><pair ddi="false" e1="DDI-PubMed.17261397.s1.e2" e2="DDI-PubMed.17261397.s1.e3" /></sentence><sentence text="We sought to determine a potential interaction between statins and antiplatelet therapy with aspirin and clopidogrel"><entity charOffset="93-100" id="DDI-PubMed.17261397.s2.e0" text="aspirin" /><entity charOffset="105-116" id="DDI-PubMed.17261397.s2.e1" text="clopidogrel" /><pair ddi="false" e1="DDI-PubMed.17261397.s2.e0" e2="DDI-PubMed.17261397.s2.e0" /><pair ddi="false" e1="DDI-PubMed.17261397.s2.e0" e2="DDI-PubMed.17261397.s2.e1" /></sentence><sentence text=" Previous laboratory studies have shown a possible drug-drug interaction of statins metabolized by cytochrome P450 3A4 and clopidogrel (prodrug metabolized by cytochrome P450 3A4), resulting in an impaired inhibitory effect of clopidogrel on platelet aggregation"><entity charOffset="123-134" id="DDI-PubMed.17261397.s3.e0" text="clopidogrel" /><entity charOffset="227-238" id="DDI-PubMed.17261397.s3.e1" text="clopidogrel" /><pair ddi="false" e1="DDI-PubMed.17261397.s3.e0" e2="DDI-PubMed.17261397.s3.e0" /><pair ddi="false" e1="DDI-PubMed.17261397.s3.e0" e2="DDI-PubMed.17261397.s3.e1" /></sentence><sentence text=" However, conclusive prospective data assessing this potentially relevant interaction are lacking" /><sentence text=" In 73 patients, 23 with previous coronary stent thrombosis (ST) (ST group) and 50 without coronary ST (control group), platelet aggregation was measured 3 times in monthly intervals using light transmission aggregometry (adenosine diphosphate [ADP] and arachidonic acid induction)"><entity charOffset="222-243" id="DDI-PubMed.17261397.s5.e0" text="adenosine diphosphate" /><entity charOffset="254-270" id="DDI-PubMed.17261397.s5.e1" text="arachidonic acid" /><pair ddi="false" e1="DDI-PubMed.17261397.s5.e0" e2="DDI-PubMed.17261397.s5.e0" /><pair ddi="false" e1="DDI-PubMed.17261397.s5.e0" e2="DDI-PubMed.17261397.s5.e1" /></sentence><sentence text=" Measurements were carried out with aspirin monotherapy (100 mg/day), dual antiplatelet therapy with aspirin plus clopidogrel (75 mg/day), and additional treatment of 20 mg/day of atorvastatin or 40 mg/day of pravastatin"><entity charOffset="36-43" id="DDI-PubMed.17261397.s6.e0" text="aspirin" /><entity charOffset="101-108" id="DDI-PubMed.17261397.s6.e1" text="aspirin" /><entity charOffset="114-125" id="DDI-PubMed.17261397.s6.e2" text="clopidogrel" /><entity charOffset="180-192" id="DDI-PubMed.17261397.s6.e3" text="atorvastatin" /><entity charOffset="209-220" id="DDI-PubMed.17261397.s6.e4" text="pravastatin" /><pair ddi="false" e1="DDI-PubMed.17261397.s6.e0" e2="DDI-PubMed.17261397.s6.e0" /><pair ddi="false" e1="DDI-PubMed.17261397.s6.e0" e2="DDI-PubMed.17261397.s6.e1" /><pair ddi="false" e1="DDI-PubMed.17261397.s6.e0" e2="DDI-PubMed.17261397.s6.e2" /><pair ddi="false" e1="DDI-PubMed.17261397.s6.e0" e2="DDI-PubMed.17261397.s6.e3" /><pair ddi="false" e1="DDI-PubMed.17261397.s6.e0" e2="DDI-PubMed.17261397.s6.e4" /><pair ddi="false" e1="DDI-PubMed.17261397.s6.e1" e2="DDI-PubMed.17261397.s6.e1" /><pair ddi="false" e1="DDI-PubMed.17261397.s6.e1" e2="DDI-PubMed.17261397.s6.e2" /><pair ddi="false" e1="DDI-PubMed.17261397.s6.e1" e2="DDI-PubMed.17261397.s6.e3" /><pair ddi="false" e1="DDI-PubMed.17261397.s6.e1" e2="DDI-PubMed.17261397.s6.e4" /><pair ddi="false" e1="DDI-PubMed.17261397.s6.e2" e2="DDI-PubMed.17261397.s6.e2" /><pair ddi="false" e1="DDI-PubMed.17261397.s6.e2" e2="DDI-PubMed.17261397.s6.e3" /><pair ddi="false" e1="DDI-PubMed.17261397.s6.e2" e2="DDI-PubMed.17261397.s6.e4" /><pair ddi="false" e1="DDI-PubMed.17261397.s6.e3" e2="DDI-PubMed.17261397.s6.e3" /><pair ddi="false" e1="DDI-PubMed.17261397.s6.e3" e2="DDI-PubMed.17261397.s6.e4" /></sentence><sentence text=" ADP (5 and 20 micromol)-induced platelet aggregation was significantly decreased with clopidogrel (p &lt;0"><entity charOffset="87-98" id="DDI-PubMed.17261397.s7.e0" text="clopidogrel" /></sentence><sentence text="001) but remained stable under additional treatment with atorvastatin or pravastatin in the 2 groups"><entity charOffset="57-69" id="DDI-PubMed.17261397.s8.e0" text="atorvastatin" /><entity charOffset="73-84" id="DDI-PubMed.17261397.s8.e1" text="pravastatin" /><pair ddi="false" e1="DDI-PubMed.17261397.s8.e0" e2="DDI-PubMed.17261397.s8.e0" /><pair ddi="false" e1="DDI-PubMed.17261397.s8.e0" e2="DDI-PubMed.17261397.s8.e1" /></sentence><sentence text=" Patients with previous ST showed a higher ADP-induced aggregation level than control subjects" /><sentence text=" This difference was not influenced by clopidogrel or statin treatment"><entity charOffset="39-50" id="DDI-PubMed.17261397.s10.e0" text="clopidogrel" /></sentence><sentence text=" In conclusion, patients with previous ST show a higher aggregation level than control subjects independent of statin treatment" /><sentence text=" Atorvastatin and pravastatin do not interfere with the antiaggregatory effect of aspirin and clopidogrel"><entity charOffset="1-13" id="DDI-PubMed.17261397.s12.e0" text="Atorvastatin" /><entity charOffset="18-29" id="DDI-PubMed.17261397.s12.e1" text="pravastatin" /><entity charOffset="82-89" id="DDI-PubMed.17261397.s12.e2" text="aspirin" /><entity charOffset="94-105" id="DDI-PubMed.17261397.s12.e3" text="clopidogrel" /><pair ddi="false" e1="DDI-PubMed.17261397.s12.e0" e2="DDI-PubMed.17261397.s12.e0" /><pair ddi="false" e1="DDI-PubMed.17261397.s12.e0" e2="DDI-PubMed.17261397.s12.e1" /><pair ddi="false" e1="DDI-PubMed.17261397.s12.e0" e2="DDI-PubMed.17261397.s12.e2" /><pair ddi="false" e1="DDI-PubMed.17261397.s12.e0" e2="DDI-PubMed.17261397.s12.e3" /><pair ddi="false" e1="DDI-PubMed.17261397.s12.e1" e2="DDI-PubMed.17261397.s12.e1" /><pair ddi="false" e1="DDI-PubMed.17261397.s12.e1" e2="DDI-PubMed.17261397.s12.e2" /><pair ddi="false" e1="DDI-PubMed.17261397.s12.e1" e2="DDI-PubMed.17261397.s12.e3" /><pair ddi="false" e1="DDI-PubMed.17261397.s12.e2" e2="DDI-PubMed.17261397.s12.e2" /><pair ddi="false" e1="DDI-PubMed.17261397.s12.e2" e2="DDI-PubMed.17261397.s12.e3" /></sentence><sentence text=" In conclusion, drug-drug interaction between dual antiplatelet therapy and atorvastatin or pravastatin seems not to be associated with ST"><entity charOffset="76-88" id="DDI-PubMed.17261397.s13.e0" text="atorvastatin" /><entity charOffset="92-103" id="DDI-PubMed.17261397.s13.e1" text="pravastatin" /><pair ddi="false" e1="DDI-PubMed.17261397.s13.e0" e2="DDI-PubMed.17261397.s13.e0" /><pair ddi="false" e1="DDI-PubMed.17261397.s13.e0" e2="DDI-PubMed.17261397.s13.e1" /></sentence><sentence text="" /></document>